Whether AI is a bubble depends on one distinction: whether AI companies are selling services — durable, recurring, process-embedded value that compounds over time — or products — features that competitors replicate, commoditize, and erode on price. Services create switching costs, institutional knowledge, and compounding ROI; products become line items competing on price. As of early 2026, the AI companies demonstrating durable value are those embedded in specific workflows with proprietary data networks — not those selling generic capability. For dental practices evaluating AI vendors, this distinction is directly practical: workflow-embedded AI with dental-specific training data builds a moat; general-purpose AI applied to dental contexts does not.
Why Venture Capital Fueled the “Bubble” Narrative
Much of the current AI bubble conversation isn’t being driven by customers or operators. It’s emerging from venture capital recalibrating after mispricing a class of AI businesses—specifically, service-layer companies that looked like products but behaved like intermediaries.
From 2023 onward, VCs faced unusual pressure:
-
Foundational AI breakthroughs created fear of missing the next platform shift
-
Time-to-demo collapsed from months to days
-
Early usage signals resembled product-market fit, even when they weren’t
In that environment, AI services layered on top of foundational models became the fastest way to deploy capital.
They were easy to understand, quick to build, and straightforward to fund.
The Pattern That Repeated
Many service-layer AI companies followed a similar path:
-
A small team wrapped a powerful foundational model
-
They demonstrated impressive outputs with minimal engineering
-
Early users showed enthusiasm driven by novelty
-
Revenue appeared quickly, often usage-based or pilot-driven
From an investor perspective, this looked like velocity.
But velocity masked fragility.
What was often missing:
-
Ownership of a core workflow
-
Meaningful switching costs
-
Proprietary data accumulation
-
Clear paths to long-term margin durability
In practice, many of these businesses functioned as professional services accelerated by AI, not products with compounding leverage.
Why This Was Especially Risky in AI
In traditional SaaS, service layers can persist because platforms evolve slowly.
In AI, the opposite is true.
Foundational providers like OpenAI, Anthropic, and Google are improving core capabilities continuously:
-
Better reasoning
-
Longer context windows
-
Native tool use
-
Memory
-
Multimodality
Each improvement compresses the value of intermediaries whose differentiation lives above the model rather than inside a workflow.
From a venture perspective, this created a critical realization:
The faster foundational models improve, the shorter the half-life of thin service layers.
That dynamic is uncommon in other software categories.
The Repricing (Not the Crash)
As foundational capabilities expanded, investors began to observe:
-
Slower renewals
-
Rising churn
-
Tool consolidation by customers
-
Pressure on pricing and margins
This forced a reassessment.
Not of AI itself—but of which AI business models could support venture-scale returns.
The result wasn’t a collapse.
It was a repricing.
Capital shifted away from:
-
Agent wrappers
-
Generic orchestration tools
-
Horizontal copilots
And toward:
-
Workflow-native systems
-
Verticalized products
-
Infrastructure-grade platforms
This shift is what many now label an “AI bubble.”
But bubbles don’t selectively deflate.
Corrections do.
Why the Bubble Narrative Misses the Point
When venture-backed service layers struggle, it’s tempting to conclude that AI was overhyped.
In reality, what was overestimated was:
-
How defensible it is to sit between users and rapidly improving platforms
-
How quickly novelty converts into durable value
-
How venture returns emerge without owning outcomes
The technology didn’t fail.
The business model assumptions did.
What Investors Are Now Optimizing For
Post-correction, investor criteria have sharpened:
-
Does the product own a mission-critical workflow?
-
Does it accumulate proprietary context over time?
-
Does usage reduce human effort rather than add steps?
-
Can it remain valuable as underlying models improve?
These questions filter out most service-layer plays immediately.
They also explain why deeply embedded, vertical AI solutions for dental products continue to raise capital—even as agent-centric businesses struggle.
Reframing the Moment
This isn’t a warning sign for AI.
It’s a warning sign for AI businesses that don’t own what they automate.
The next decade of AI value creation won’t be won by:
-
assembling intelligence,
-
showcasing outputs,
-
or standing adjacent to workflows.
It will be won by products that:
-
carry responsibility,
-
compound context,
-
and become operationally unavoidable.
That’s not a bubble bursting.
That’s venture capital rediscovering fundamentals—inside an AI-shaped market.
FAQs
Q1: What are AI agent builders?
Tools that let teams assemble custom AI agents by chaining prompts and logic without needing deep engineering expertise.
Q2: How does the ChatGPT App Store impact AI startups?
By centralizing AI agents on a trusted platform, it reduces space for fragmented third-party agent builders.
Q3: Is AI itself a bubble?
No. Foundational AI models and deeply integrated applications represent durable innovation.
Q4: What defines durable AI products?
Embedding in workflows, accumulating context, reducing user friction, and aligning intelligence with compliance and outcomes.
Q5: How is OraCore positioned in this landscape?
OraCore embeds AI deeply into clinical workflows, prioritizing continuity, accuracy, and invisibility, avoiding agent-layer vulnerabilities.
Frequently Asked Questions
The bubble question has become more nuanced by 2026. AI investment clearly outpaced near-term revenue in 2023–2024, consistent with bubble dynamics. By early 2026, enterprise AI adoption has accelerated meaningfully — the bubble framing fits consumer AI hype better than enterprise AI deployment reality. The honest answer: general-purpose AI consumer products face margin compression and commoditization consistent with bubble correction; industry-specific AI embedded in proprietary workflows shows genuine durable value. The right question isn’t ‘is AI a bubble?’ — it’s ‘which parts of AI are products and which are services?’
An AI product delivers a specific feature or output — a transcription, an image, an answer. Products commoditize: once the capability is common, differentiation becomes price. An AI service embeds in workflows, accumulates institutional knowledge, and creates switching costs over time. A dental AI scribe that learns a practice’s documentation preferences, integrates with its PMS, and generates notes that don’t require editing anymore is a service — the longer you use it, the more embedded and valuable it becomes. A generic transcription tool that produces text is a product — easily replaced by the next vendor offering the same output at lower cost.
It directly informs vendor selection strategy. If a dental AI vendor is selling a product (a generic capability with dental labeling), the risk is that the capability commoditizes and either the price collapses or the vendor is acquired and the product is discontinued. If the vendor is building a service (dental-specific training data, deep PMS integration, institutional practice knowledge), the switching cost argument works in both directions — it’s worth more to keep using it over time. Evaluate vendors on data specificity, integration depth, and whether the product improves with use — these are service characteristics.
GPT model commoditization and API access created a low barrier to building dental-labeled AI products on top of general-purpose models: take a foundational language model, add a dental system prompt, build a simple interface, and market it as ‘AI for dentists.’ The proliferation was inevitable given how low the technical entry cost became. Most of these tools are products in the product-vs-service framework — they deliver a general capability with dental labeling, not a dental-specific capability with proprietary training data. The differentiation pressure on these tools is intense because any competitor can build a similar product at similar cost.
Three characteristics predict durability: (1) Proprietary dental training data — a model trained on dental clinical language, CDT codes, and perio charting structures performs better on dental tasks and isn’t replicable by building a competitor product on a general model; (2) Deep workflow integration — AI embedded in the actual clinical and billing workflow creates switching costs; (3) Network effects — AI that improves with practice-level usage data builds a moat that doesn’t exist in day one. Dental AI scribes with these three characteristics are services; general-purpose AI with dental labels are products.
Three signals of vendor durability worth evaluating: (1) Specialization depth — a vendor building specifically for dentistry is more defensible than one serving multiple healthcare verticals with generic AI; (2) Integration investment — a vendor with direct PMS integrations (which require significant engineering investment to build and maintain) has made commitments that signal longevity; (3) Data network effects — does the product improve with usage data? A vendor whose AI gets better the more practices use it has a compounding advantage that pure-play products lack. None of these guarantees survival — but all three are better predictors than funding round size or marketing claims.
As of early 2026, OpenAI operates both models: ChatGPT consumer products (product dynamics — broad access, commodity pressure, rapid model iteration) and enterprise API contracts (service dynamics — embedded in workflows, pricing based on usage). The tension between these models reflects the broader AI market structure. For dental practices, the implications are indirect: the companies building on OpenAI’s API to create dental-specific applications inherit OpenAI’s model updates but add their own service layers (integration, training data, workflow embedding) on top. Evaluate the dental AI vendor’s service layer, not just the underlying model.
When evaluating any dental AI vendor, ask: ‘If you doubled your price tomorrow, would we still keep using it?’ That’s the service test. If the answer is yes (because switching costs, integration depth, and documented results make the value clear), you’re buying a service. If the answer is ‘we’d immediately look for alternatives’ (because another vendor could provide the same generic capability at lower cost), you’re buying a product. Products are fine to use; just don’t build your practice’s operational infrastructure on them. Services are worth paying for and protecting as core practice infrastructure.